Exencial Wealth Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Sell |
7,735
-1,868
| -19% | -$56.2K | 0.01% | 465 |
|
|
2025
Q1 | $274K | Sell |
9,603
-335
| -3% | -$9.55K | 0.01% | 435 |
|
|
2024
Q4 | $328K | Buy |
9,938
+134
| +1% | +$4.43K | 0.01% | 411 |
|
|
2024
Q3 | $366K | Sell |
9,804
-487
| -5% | -$18.2K | 0.01% | 406 |
|
|
2024
Q2 | $346K | Sell |
10,291
-674
| -6% | -$22.6K | 0.01% | 406 |
|
|
2024
Q1 | $392K | Sell |
10,965
-1,103
| -9% | -$39.4K | 0.01% | 393 |
|
|
2023
Q4 | $398K | Sell |
12,068
-197
| -2% | -$6.49K | 0.02% | 372 |
|
|
2023
Q3 | $334K | Buy |
12,265
+79
| +0.6% | +$2.15K | 0.02% | 345 |
|
|
2023
Q2 | $384K | Sell |
12,186
-630
| -5% | -$19.9K | 0.02% | 333 |
|
|
2023
Q1 | $348K | Sell |
12,816
-1,238
| -9% | -$33.7K | 0.02% | 328 |
|
|
2022
Q4 | $427K | Buy |
14,054
+103
| +0.7% | +$3.13K | 0.02% | 307 |
|
|
2022
Q3 | $420K | Sell |
13,951
-488
| -3% | -$14.7K | 0.03% | 295 |
|
|
2022
Q2 | $400K | Buy |
14,439
+226
| +2% | +$6.26K | 0.02% | 297 |
|
|
2022
Q1 | $478K | Buy |
14,213
+3,290
| +30% | +$111K | 0.02% | 291 |
|
|
2021
Q4 | $461K | Buy |
+10,923
| New | +$461K | 0.02% | 326 |
|
|
2021
Q3 | – | Sell |
-8,752
| Closed | -$428K | – | 429 |
|
|
2021
Q2 | $428K | Buy |
8,752
+2,287
| +35% | +$112K | 0.02% | 336 |
|
|
2021
Q1 | $325K | Buy |
6,465
+237
| +4% | +$11.9K | 0.02% | 344 |
|
|
2020
Q4 | $319K | Sell |
6,228
-7,671
| -55% | -$393K | 0.02% | 301 |
|
|
2020
Q3 | $572K | Buy |
13,899
+6,835
| +97% | +$281K | 0.03% | 241 |
|
|
2020
Q2 | $295K | Buy |
+7,064
| New | +$295K | 0.03% | 270 |
|